Literature DB >> 19048707

Abrikossoff cell tumor of the oesophagus: a case report and review of the literature.

F Marolleau1, F Baert, V Mertens, G Ghillebert.   

Abstract

Abrikossoff tumours or granular cell tumours are rare and usually benign tumours. The oesophagus is a rare location (0.001% of all tumours). The macroscopic appearance is typical (yellow, firm, well circumscribed submucosal neoplasm-like with reduced vascular patterns) but due to the rarity of this lesion, it can be mistaken with other similar lesions. This is the report of a case of a 47-year-old female with a granular cell tumour of the distal oesophagus. In this case, the Abrikossoff tumour is clinically, radiologically en histologically benign. According to the fact that there is low evidence in the literature for removing such Lesions in patient without symptoms, it was decided to be conservative. In this paper we discuss the case with review of the Literature with emphasis on the diagnosis, evaluation and management.

Entities:  

Mesh:

Year:  2008        PMID: 19048707     DOI: 10.1179/acb.2008.050

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  4 in total

Review 1.  [Incidental findings in gastroscopy and colonoscopy].

Authors:  J W Rey; A Hoffman; A Rambow; R Kiesslich
Journal:  Internist (Berl)       Date:  2014-09       Impact factor: 0.743

2.  Esophageal Granular Cell Tumor: A Benign Tumor or an Insidious Cause for Concern?

Authors:  Kiranya Tipirneni; Ashley Mehl; Blythe Bowman; Virendra Joshi
Journal:  Ochsner J       Date:  2016

3.  Abrikossoff Tumor (Granular Cell Tumor) Presenting in the Esophagus.

Authors:  Kevin Groudan; Jean Chalhoub; Rohit Singhania
Journal:  Cureus       Date:  2021-02-11

4.  Isolated Hypoglossal Nerve Palsy as an Early Symptom of a Granular Cell Tumor.

Authors:  Juliana Lemound; Dimitrios Papadimas; Sabine Skodda; Andrea Tannapfel; Anriy Alekseyev; Martin Kunkel
Journal:  Int J Environ Res Public Health       Date:  2022-02-25       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.